Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials (Q34612162)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials |
scientific article |
Statements
1 reference
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials (English)
1 reference
Mihai Gheorghiade
1 reference
Liliana Grinfeld
1 reference
Faiez Zannad
1 reference
Karl Swedberg
1 reference
James E Udelson
1 reference
Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
1 reference
Christopher Zimmer
1 reference
Marvin A Konstam
1 reference
John C Burnett
1 reference
Aldo P Maggioni
1 reference
Thomas Cook
1 reference
John Ouyang
1 reference
Cesare Orlandi
1 reference
25 March 2007
1 reference
1 reference
Identifiers
1 reference